locally advanced
Showing 1 - 19 of 19
Combined Postoperative Radiotherapy With Kidney Sparing Surgery
Recruiting
- Locally Advanced
- Urothelial Carcinoma Ureter
- Radical surgery
- Kidney sparing surgery+Postoperative radiotheray
-
Beijing, China
- +1 more
Nov 2, 2023
Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- +2 more
- standard Radiotherapy
- +3 more
- (no location specified)
Oct 20, 2023
Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- CTV omitted or delineated
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Sep 1, 2023
Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced
- +3 more
- Toripalimab
- +3 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital Southern Medical University
May 17, 2023
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023
Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- Locally Advanced
- Later-line therapy
-
Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023
Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Locally Advanced
- Non-small Cell Lung Cancer
- Serplulimab
- +5 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
Mar 14, 2023
Sentinel Lymph Node, Breast Cancer, Locally Advanced Trial in Hospitalet de Llobregat, Barcelona (Target Axillary Dissection)
Recruiting
- Sentinel Lymph Node
- +2 more
- Target Axillary Dissection
-
Hospitalet de Llobregat, Barcelona, Spain
- +1 more
Mar 11, 2023
Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body
Not yet recruiting
- Pancreas Cancer
- +2 more
- Stereotactic Ablative Body Radiation (SABR)
- Tumor Treating Fields (TTF)
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022
Urothelial Carcinoma, Locally Advanced, Unresectable Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)
Active, not recruiting
- Urothelial Carcinoma
- +2 more
- Atezolizumab
- +2 more
-
Chicago, Illinois
- +8 more
Dec 23, 2022
Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- Locally Advanced
- Short-course radiotherapy
- +3 more
- (no location specified)
Oct 8, 2022
Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)
Active, not recruiting
- Head and Neck Cancer
- Locally Advanced
- Palbociclib
- +2 more
-
Bangkok, ThailandFaculty of Medicine, Ramathibodi Hospital
Sep 19, 2022
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Solid Tumor, Metastasis, Locally Advanced Trial in Yongin-si (IMC-001)
Completed
- Solid Tumor
- +2 more
-
Yongin-si, Gyeonggi-do, Korea, Republic ofImmuneOncia
May 26, 2020
Cancer, Colon Cancer, Colorectal Cancer Trial in Worldwide (Pegfilgrastim, Placebo, Bevacizumab)
Colorectal Cancer, Locally Advanced, Metastatic Cancer Trial (AMG 479, AMG 655)
Terminated
- Colorectal Cancer
- +7 more
- AMG 479
- AMG 655
- (no location specified)
Nov 2, 2016
Adenocarcinoma of the Pancreas, Locally Advanced, Unresectable Trial in Worldwide (Gemcitabine, AMG 479, Placebo)
Terminated
- Adenocarcinoma of the Pancreas
- +2 more
- Gemcitabine
- +2 more
-
San Francisco, California
- +34 more
Aug 6, 2014
Unresectable, Locally Advanced, Metastatic Trial in Vienna (Cetuximab + Gemcitabine + Oxaliplatin)
Completed
- Unresectable
- +2 more
- Cetuximab + Gemcitabine + Oxaliplatin
-
Vienna, AustriaKH Rudolfstiftung
Oct 6, 2010
Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Pittsburgh (gemcitabine, epirubicin,
Completed
- Stage IIB Breast Cancer
- +5 more
- gemcitabine, epirubicin, paclitaxel
-
Pittsburgh, PennsylvaniaNSABP Foundation, Inc.
Nov 24, 2008